SCHEMBL66214

SCHEMBL66214

c1cnc2nccn2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2161951 0.97 PDE10A (0.43)
Hydrochloric Acid SCHEMBL30051365 0.97 PDE10A (0.43)
Perchlorate SCHEMBL2161880 0.87 ALDH1A1 (0.37)
SCHEMBL13740204 0.71 ALDH1A1 (0.47)
SCHEMBL1062021 0.70
SCHEMBL10893 0.69
SCHEMBL23090057 0.67 ALDH1A1 (0.57)
SCHEMBL22448220 0.67 ALDH1A1 (0.53)
SCHEMBL3156629 0.67 ALDH1A1 (0.57)
SCHEMBL8811701 0.67 ALDH1A1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2786 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4231329-B1 PEROVSKITE SOLAR CELL AND MANUFACTURING METHOD CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD (HK) 2026-03-25 EP claimed
US-20250333399-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KHORA SPV 1 LLC (US) 2025-10-30 US claimed
EP-4611899-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 EP claimed
US-12376486-B2 Perovskite solar cell and manufacturing method CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-07-29 US claimed
US-12342717-B2 2025-06-24 US claimed
EP-4568972-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2025-06-18 EP claimed
CN-119661811-A Latent accelerator based on anhydride-tertiary amine dynamic ion pair, preparation method and application thereof 江南大学 2025-03-21 CN claimed
CN-119654326-A Novel heterocyclic compounds 豪夫迈·罗氏有限公司 2025-03-18 CN claimed
CN-118772148-A Imidazo [1,2-a ] pyrimidine matrine/sophoridine derivative, preparation method and application 西北农林科技大学 2024-10-15 CN claimed
US-20240182460-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION 2024-06-06 US claimed
WO-1991019497-A1 INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1991-12-26 WO claimed
US-5017212-A For rice paddies TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-05-21 US claimed
EP-0197230-B1 Imidazo[1,2-a]pyrimidines and their salts with the acids, process and intermediates for their preparation, use as medicaments and compositions containing them ROUSSEL-UCLAF (FR) 1990-01-31 EP claimed
EP-0238070-A2 Sulfonylurea compounds, their production and herbicidal use Takeda Chemical Industries, Ltd. (JP) 1987-09-23 EP claimed
EP-0113236-B1 SUBSTITUTED IMIDAZOPYRIMIDINES-PYRAZINES, AND -TRIAZINES ELI LILLY AND COMPANY (US) 1987-04-22 EP claimed
EP-0185345-A1 Imidazo derivatives, their preparation and medicines containing them Dr. Karl Thomae GmbH (DE) 1986-06-25 EP claimed
US-4588720-A ANXIOLYTIC AGENTS ROUSSEL UCLAF (FR) 1986-05-13 US claimed
US-4532243-A Imidazo(1,2-a)pyrimidines and their salts useful for treating anxiety ROUSSEL UCLAF (FR) 1985-07-30 US claimed
EP-0068302-A1 Imidazo (1,2-a) pyrimidines, their acid-addition salts, medicinal preparations containing them and process for their preparation BOEHRINGER INGELHEIM KG (DE) 1983-01-05 EP claimed
EP-0061380-A1 Imidazo (1,2-a) pyrimidine derivatives, their preparation and their therapeutical use SYNTHELABO (FR) 1982-09-29 EP claimed